Cardiology News and Research

Latest Cardiology News and Research

New study reports more practical approach to heal the heart after a heart attack

Stem cell have been the main focus of healing therapy research because they can morph into new cells, and using a patient's own stem cells will not induce an autoimmune response. For healing after a heart attack, the ideal time to administer these therapies is when reopening the clogged blood vessel because the heart is easily accessible. While stem cells show promise for heart attack treatment, the process of harvesting and reintroducing the cells—which can take days or weeks—is too slow for this window.

17 Jun 2015

DCRI announces new study to better understand lipid management

At a time when lipid management in the United States is undergoing transition in response to new guideline recommendations and expanding lipid-lowering therapy options, the Duke Clinical Research Institute (DCRI) today announced a new study to better understand contemporary lipid management as well as the beliefs and attitudes of patient and providers regarding cholesterol, cardiovascular risk assessment, and options for lipid treatments.

17 Jun 2015

Atopix raises additional development capital to investigate OC459 for treatment of asthma

Atopix Therapeutics Limited, a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product OC459 for the treatment of asthma.

17 Jun 2015

Study: Nut consumption associated with decreased risk of some types of cancer, but not type 2 diabetes

Cancer and type 2 diabetes are two of the most significant public health burdens facing the world today, and currently available data suggests their prevalence is expected to continue to increase. Nut consumption has long been hypothesized to have a role in preventing both of these diseases, but until now evidence has been inconsistent.

17 Jun 2015

UCSF researchers find that people divided on cardiovascular benefits of alcohol consumption

In one of the first published studies using data from the Health eHeart Study, UCSF researchers have found that people are divided on the cardiovascular benefits of alcohol consumption. And, those who do perceive alcohol as "heart healthy" drink substantially more than their counterparts.

17 Jun 2015

Women with significant depressive symptoms have lower levels of klotho hormone

Women under chronic stress have significantly lower levels of klotho, a hormone that regulates aging and enhances cognition, researchers at UC San Francisco have found in a study comparing mothers of children on the autism spectrum to low-stress controls.

17 Jun 2015

Future Cardiology’s special issue focuses on recent advances, challenges in cardiology

In recognition of 10 years of publication Future Cardiology has launched a special issue focused on recent advances and emerging challenges in specific areas of cardiology.

17 Jun 2015

Soil microbe prevents arsenic accumulation in rice plants

University of Delaware researchers have discovered a soil microbe that mobilizes an "iron shield" to block the uptake of toxic arsenic in rice.

17 Jun 2015

WSU researchers receive U.S. patent for new anesthesia monitoring system

A team of researchers from Wayne State University was recently issued a U.S. patent (# 8,998,808) on a technology that will offer anesthesiologists better methods for monitoring and managing patients in the operating room.

17 Jun 2015

Phase I study: Idarucizumab reverses anticoagulant effect of dabigatran in healthy volunteers

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that The Lancet published results from a phase I study investigating the effects of idarucizumab, an investigational agent, in reversing the anticoagulant effect of dabigatran in healthy volunteers. The data demonstrate that complete reversal was achieved following administration of idarucizumab.

17 Jun 2015

FDA grants Fast Track designation to Juventas' JVS-100 drug candidate and allows Phase 2b clinical trial

Juventas Therapeutics, Inc., a clinical-stage biotechnology company developing novel non-viral gene therapies that activate natural processes to repair the body, today announced that its product candidate, JVS-100, received Fast Track designation from the U.S. Food and Drug Administration for the treatment of advanced ischemic chronic heart failure.

16 Jun 2015

MedUni Vienna uses new MR technique to classify adenomas

Adenomas are rare liver tumours, a certain percentage of which can become malignant. Using a new MR (magnetic resonance) technique at MedUni Vienna, it is now possible to classify adenomas without subjecting patients to invasive tissue sampling procedures.

16 Jun 2015

Improving air quality could prevent pollution-related deaths worldwide

Improving air quality -- in clean and dirty places -- could reduce pollution-related deaths worldwide by millions of people each year. That finding comes from a team of environmental engineering and public health researchers who developed a global model of how changes in outdoor air pollution could lead to changes in the rates of health problems such as heart attack, stroke and lung cancer.

16 Jun 2015

WHO and World Bank Group: 400 million people do not have access to essential health services

A World Health Organization and World Bank Group report launched today shows that 400 million people do not have access to essential health services and 6% of people in low- and middle-income countries are tipped into or pushed further into extreme poverty because of health spending.

16 Jun 2015

Pharmacists play vital role in improving health of patients with Type 2 diabetes

Over the past nine years, Scot H. Simpson, professor in the faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta, has been studying the role of pharmacists on primary care teams and their impact on the health of patients with Type 2 diabetes.

16 Jun 2015

Mayo Clinic, United Therapeutics partner to build and operate new lung restoration center on Mayo campus

Mayo Clinic in Jacksonville, Fla., and United Therapeutics Corporation today announced a collaboration to build and operate a lung restoration center on the Mayo campus. The goal is to significantly increase the volume of lungs for transplantation by preserving and restoring selected marginal donor lungs, making them viable for transplantation. The restored lungs will be made available to patients at Mayo Clinic and other transplant centers throughout the United States.

16 Jun 2015

Scientists report that mouse with weak bones appears to have strong metabolism

One mouse with weak bones appears to have a strong metabolism, even on a high-fat diet, scientists report. While weaker bones are clearly not a good thing, scientists suspect that, somewhere in the conversation between the genetically engineered mouse's skeleton and the rest of its body, there may be an answer that helps obese individuals avoid some of the worst ravages of this health epidemic.

16 Jun 2015

Scientists find way to accelerate wound healing in diabetic mice

One of the body's own tools for preventing wound infections may actually interfere with wound healing, according to new research from Boston Children's Hospital. In a study published online in Nature Medicine, scientists from the hospital's Program in Cellular and Molecular Medicine found they could speed up wound healing in diabetic mice by keeping immune cells called neutrophils from producing bacteria-trapping neutrophil extracellular traps (NETs).

15 Jun 2015

Men's poor health costs $36.9 billion a year for Canada

Canadian Men's Health Week is kicking off with an urgent message: Unhealthy lifestyle choices are running rampant, and they are costing this country an arm and a leg.

15 Jun 2015

Researchers identify gene variant that makes breast cancer cells more aggressive

A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches.

15 Jun 2015

Cardiology News and Research

Latest Cardiology News and Research

New study reports more practical approach to heal the heart after a heart attack

DCRI announces new study to better understand lipid management

Atopix raises additional development capital to investigate OC459 for treatment of asthma

Study: Nut consumption associated with decreased risk of some types of cancer, but not type 2 diabetes

UCSF researchers find that people divided on cardiovascular benefits of alcohol consumption

Women with significant depressive symptoms have lower levels of klotho hormone

Future Cardiology’s special issue focuses on recent advances, challenges in cardiology

Soil microbe prevents arsenic accumulation in rice plants

WSU researchers receive U.S. patent for new anesthesia monitoring system

Phase I study: Idarucizumab reverses anticoagulant effect of dabigatran in healthy volunteers

FDA grants Fast Track designation to Juventas' JVS-100 drug candidate and allows Phase 2b clinical trial

MedUni Vienna uses new MR technique to classify adenomas

Improving air quality could prevent pollution-related deaths worldwide

WHO and World Bank Group: 400 million people do not have access to essential health services

Pharmacists play vital role in improving health of patients with Type 2 diabetes

Mayo Clinic, United Therapeutics partner to build and operate new lung restoration center on Mayo campus

Scientists report that mouse with weak bones appears to have strong metabolism

Scientists find way to accelerate wound healing in diabetic mice

Men's poor health costs $36.9 billion a year for Canada

Researchers identify gene variant that makes breast cancer cells more aggressive

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Cardiology News and Research

Latest Cardiology News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in